Cell, gene ther­a­py man­u­fac­tur­ing takes cen­ter stage as No­var­tis, Ama­zon join forces

Tech gi­ants have pen­e­trat­ed the realm of health­care. Mean­while, the bio­phar­ma­ceu­ti­cal in­dus­try has em­braced the promise of dig­i­tal drug de­vel­op­ment and med­i­cine as it ush­ers in the era of telemed­i­cine, wear­ables, cloud com­put­ing, ma­chine learn­ing and ar­ti­fi­cial in­tel­li­gence. No­var­tis, which was one of the pi­o­neer­ing large drug­mak­ers to hire a chief dig­i­tal/tech­nol­o­gy of­fi­cer in 2017, has now tied up with the wide­ly used cloud plat­form Ama­zon Web Ser­vices to stream­line its man­u­fac­tur­ing, sup­ply chain, and de­liv­ery op­er­a­tions.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.